Combat zone exposure and respiratory tract disease by Parsel, Sean M. et al.
REVIEW ART ICLE
Combat zone exposure and respiratory tract disease
Sean M. Parsel, DO1 , Charles A. Riley, MD2 and Edward D. McCoul, MD, MPH3,4
Background: The impact of deployment to combat zones
on the respiratory and sinonasal health of U.S. soldiers is
an emerging public health concern. Retrospective studies
have shown a correlation between deployment and devel-
opment of post-deployment pathology, particularly of the
aerodigestive system. Respiratory disease, including sinusi-
tis, allergic rhinitis, and asthma, are commonly reported in
soldiers deployed to the Middle East and Southwest Asia.
Methods: Current literature pertaining to combat zone
exposure and development of respiratory disease was
retrieved using PubMed, Embase, Web of Science, and
Google Scholar.
Results: Several types of combat zone exposures exist
that may play an inﬂuential role in the development of up-
per and lower respiratory tract diseases. Exposures includ-
ing foreign dusts, harsh environments, particulate size, and
close living quarters may play a causative role. The eﬀect
of combat zone exposures has been beer examined for
lower respiratory tract diseases; however, with the theory
of the uniﬁed airway, the upper respiratory tract may also
be involved. There is evidence that the upper respiratory
tract is susceptible, with an increased risk for development
of sinusitis and sinonasal disease; however, the quality of
evidence of the present literature is generally low.
Conclusion: More research is necessary to determine a
pathophysiologic mechanism between combat zone expo-
sure and the development of sinonasal disease. Practic-
ing otolaryngologists should be aware of the possibility of
combat zone exposures that could contribute to rhinologic
symptomatology. C© 2018 ARS-AAOA, LLC.
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T he impact of deployment to combat zones on the res-piratory and sinonasal health of U.S. soldiers is an
emerging public health concern. Anecdotal reports in the
popular media suggest new or worsening respiratory dis-
ease after return from a tour of duty; however, prospec-
tive data are lacking to substantiate these claims. The U.S.
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Armed Forces has over 1.3 million active duty servicemen
and servicewomen with over 300,000 of these personnel
deployed to regions outside of the United States. These in-
dividuals may be at risk for a variety of occupational expo-
sures, which can be hazardous to their respiratory health.
In addition to the direct threat of combat, soldiers often
face difficult environmental conditions, including exposure
to foreign particulate matter and close-quarters living con-
ditions. Furthermore, there is the threat of toxic chemical
agents either in the environment or when used as a weapon
by opposing forces.
Retrospective studies have shown a correlation between
deployment and development of post-deployment pathol-
ogy, particularly of the aerodigestive system.1,2 A causative
link is largely speculative and data are predominantly pro-
vided through subjective patient reports. However, res-
piratory disease, including sinusitis, allergic rhinitis, and
asthma, have been reported as the most common nonpsy-
chiatric clinical diagnoses among Iraq and Afghanistan
veterans.3
Environmental and living conditions in foreign combat
theaters can be drastically different from conditions in the
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TABLE 1. Summary of common symptoms and respiratory tract diagnoses in individuals with a history of combat zone
exposures
Anatomic region Symptoms Respiratory tract pathology
Upper respiratory tract Nasal congestion, postnasal drip, rhinorrhea, sore
throat, hyposmia
Allergic rhinitis, nonallergic rhinitis, chronic sinusitis,
recurrent acute sinusitis
Lower respiratory tract Coughing, shortness of breath, wheezing Asthma, acute bronchitis, chronic bronchitis,
constrictive bronchiolitis
United States. Deployed soldiers are exposed to foreign
dusts, harsh environments, and close living quarters. These
conditions have been associated with the development of
respiratory disease, including disease of the sinonasal tract.4
Despite anecdotal information and public media reports,
the scientific literature is less clear as to how these ex-
posures affect the health of deployed service members.
Table 1 summarizes the most common symptoms and diag-
noses of the respiratory tract associated with combat zone
exposures.
In this review we summarize the available scientific
knowledge about environmental and occupational expo-
sures on respiratory health in U.S. soldiers stationed in the
Middle East and Southwest Asia.
Impact on the lower respiratory tract
Disease of the lower respiratory tract (LRT) has been asso-
ciated with service member deployment to Southwest Asia
and the Middle East (Table 2). Up to 69% of soldiers have
been affected to some degree by respiratory ailments,4 with
asthma being the most commonly reported new respiratory
diagnosis in the literature.5–7 Most reports have suggested
a correlation exists between deployment and reversible ob-
structive disease, whereas others showed no increase in
risk.8,9 Among veterans with recent deployment to Iraq
and/or Afghanistan, Szema et al demonstrated a signifi-
cantly increased rate of respiratory symptoms and changes
in pulmonary function compared with soldiers stateside.10
In that cohort of 1,787 veterans, 14% presented with new-
onset respiratory symptoms that required evaluation with
spirometry upon returning home.Much of the literature has
focused on patient-reported symptoms of respiratory dis-
ease as opposed to objective findings for diagnosis. Barth
et al suggested an increase in reported respiratory disease
with respiratory exposures (eg, exposure to dust, smoke,
chemicals, and pollutants).11 In studies supporting the de-
velopment of respiratory disease after deployment, themost
commonly cited risk factors were duration of deployment
and number of deployments.12–14 Other associations in-
clude exposure to chemical fires, incineration of human
and solid waste, dust storms, and combat smoke.15
Despite this suggested correlation, the development of
true respiratory disease is controversial.16 In a recent
prospective study of 46,077 deployed soldiers, an increased
risk of asthma or chronic obstructive pulmonary disease
was not found. Despite this, there was a significantly in-
creased number of deployed individuals complaining of
new-onset respiratory symptoms (cough or shortness of
breath) independent of smoking status. A new-onset cough
was the most significant symptom, the risk of which was
dependent on the duration of deployment. Notably, the
increased risk of new symptoms was only significant in sol-
diers who underwent a land-based deployment.17 Chen et
al. demonstrated an inverse relationship with spirometric
findings and duration of deployment, suggesting that the
longer duration increases the risk of objective changes in
lung function.12
Impact on the upper respiratory tract
In contrast to the LRT, there is less evidence defining a
causative role for combat zone exposure in developing
pathology of the upper respiratory tract (URT). However,
given the histologic similarities of the exposed tissue, it
is plausible that environmental exposures leading to LRT
pathology also affect the URT, including the paranasal si-
nuses. The phenomenon of the unified airwaywas proposed
over a decade ago and there is mounting evidence support-
ing this process.18,19 These 2 regions of the airway share
similar epithelium and studies have shown that inflamma-
tion in one location may lead to an inflammatory response
in the other.20 Table 3 summarizes the clinical studies ad-
dressing URT manifestations of combat zone exposures.
Sinus disease has been documented as one of the lead-
ing ailments in deployed soldiers to the Middle East.21
In a large-scale retrospective study using tissue obtained
from Gulf War (1990-1999) veterans, Ladich et al demon-
strated that chronic sinusitis and allergic rhinitis were
the most common pathologies identified on histologic
examination.22 Similarly, self-reported symptoms of sol-
diers deployed during Operation Desert Shield in Saudi
Arabia (1990-1991) show increased complaints of persis-
tent rhinorrhea after deployment.23 These symptoms were
also associated with exposure to outdoor conditions and
living in tents. Multiple other upper respiratory complaints
were demonstrated, supporting the hypothesis that envi-
ronmental exposure increases mucosal inflammation. In a
retrospective study of Australian soldiers in the PersianGulf
War, sinus symptoms were reported at higher frequency
in the post-deployment cohort compared with controls.24
Similar findings were demonstrated in a more recent study
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TABLE 2. Summary of findings from clinical studies involving the lower respiratory tract
Reference (first author) Design
Location of
deployment/conflict (year) Significant findings
Abraham5 Case-control OEF/OIF (2001-2005) Increased rate of respiratory symptoms after deployment;
deployment duration not associated with development of
obstructive respiratory disease
Abraham7 Retrospective cohort OIF (2005-2007) 25% increase in rates of respiratory symptoms; 54%
increase in rates of asthma
Barth11 Retrospective survey OEF/OIF (2001-2008) Exposure linked to respiratory disease regardless of
deployment
DelVecchio16 Retrospective cohort OEF/OIF (2005-2009) No significant difference in incidence of asthma or PFTs
based on deployment status; asthma severity
classification did not differ between groups
Falvo14 Cross-sectional analysis Iraq/Afghanistan
(2012-2015)
Longer deployment duration associated with increased
FEV1/FVC
Holley13 Retrospective review OEF/OIF (2012-2013) Increased rate of spirometric abnormalities in those with
respiratory complaints
King15 Case series Iraq/Afghanistan
(2004-2009)
Constrictive bronchiolitis found in lung biopsies of those
exposed to particulate matter leading to dyspnea
Matthews9 Retrospective cohort Southwest Asia
(2005-2009)
Deployment status did not affect COPD diagnosis
Morris6 Prospective cohort Iraq/Afghanistan (2010) Airway hyperreactivity was the most common cause of
abnormal PFTs
Sanders4 Cross-sectional survey Afghanistan (2003-2004) Respiratory illness reported by 69.1% of deployed
respondents; 22.5% developed allergy attack; 3.6% had
asthma attack
Sharkey8 Retrospective cohort OEF/OIF (2002-2011) 62% increased incidence of asthma compared with
U.S.-stationed service members
Smith17 Prospective cohort Iraq/Afghanistan
(2001-2003)
Land-based veterans had higher rates of respiratory
symptoms than offshore veterans
Szema10 Retrospective cohort Iraq/Afghanistan
(2004-2010)
New-onset asthma was 6 times higher in deployed group; no
difference in FEV1/FVC values between groups
COPD = chronic obstructive pulmonary disease; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; OEF = Operation Enduring Freedom; OIF =
Operation Iraqi Freedom; PFT = pulmonary function test.
with U.S. soldiers deployed to Afghanistan and Iraq during
Operations Enduring Freedom and Iraqi Freedom (2001
to present). Patients in that study showed a significantly
increased risk for sinusitis after deployment, but not LRT
disorders such as asthma or bronchitis.25 This trend of in-
creased sinonasal inflammation has been reported in other
countries as well.24
An increased incidence of allergic rhinitis has been re-
ported in soldiers deployed in the Persian Gulf War.26 Due
to the presence of indigenous grass, weed, tree pollens, as
well as mold in Middle Eastern countries, there is a risk for
development of allergic rhinitis in previously unsensitized
individuals. Allergic rhinitis, in turn, may predispose a
deployed soldier to development of other URT disease
such as sinusitis.27 These exposures increase morbidity
while abroad and may lead to increased health burden
upon returning home. According to a large systematic
review addressing the international prevalence of allergic
rhinitis, the most commonly reported aeroallergens in the
Middle East were Salsola species and other weed pollens.28
Other allergens were dust mites, cockroaches, and other
grass and weed pollens. A similar spectrum of allergens
are present in North America; however, the particular
species vary, suggesting the potential for unsensitized
individuals to develop new atopic symptoms after foreign
exposures.29
Chemical exposures
An area of particular concern for deployed soldiers is the
risk for exposure to environmental chemicals as well as
chemical weapons, which may have an effect on the respi-
ratory mucosa. Acute rhinologic symptoms are commonly
associated with occupational exposures to a variety of
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TABLE 3. Summary of findings from clinical studies involving the upper respiratory tract
Reference (first author) Design
Location of
deployment/conflict (year) Significant findings
Barth11 Retrospective survey OEF/OIF (2001-2008) 80% risk for sinusitis after exposure
Barth25 Retrospective cohort OEF/OIF (2001-2008) Prevalence of sinusitis higher in deployed group; no
significant increase in rates of asthma
Brennan21 Retrospective cohort OIF (2004-2005) 15% of all otolaryngology visits were due to sinusitis
Kelsall24 Cross-sectional survey PGW (1990-1991) Higher rates of sinus complaints in deployed vs nondeployed
respondents (aOR = 1.5)
Ladich22 Cohort study PGW (not specified) Most common histology of deployed soldiers was chronic
sinusitis and allergic rhinitis
Richards23 Retrospective survey ODS (1990-1991) Chronic rhinorrhea found in 15.4% of respondents, higher
than in nondeployed; rhinorrhea associated with outdoor
living; cough and sore throat also common findings
Sanders4 Retrospective survey Iraq/Afghanistan
(2003-2004)
22.5% of deployed soldiers reported allergy attacks during
deployment
Szema26 Retrospective cohort Persian Gulf region
(2004-2007)
Association with deployment and development of allergic
rhinitis (9.9% vs 5.1%)
aOR = adjusted odds ratio; ODS = Operation Desert Shield; OEF = Operation Enduring Freedom; OIF = Operation Iraqi Freedom; PGW = Persian Gulf War.
chemical agents.30 In general, little is known about the spe-
cific long-term respiratory health effects of single, repeated,
or chronic exposures to chemical agents encountered in
combat zones.
One chemical class with a reported correlation between
exposure and development of URT symptoms and disease
are sulfur mustards (SMs). SMs are alkylating agents that
induce the formation of reactive oxygen species after deple-
tion of glutathione, exposure to which directly affects skin
andmucousmembranes and leads to inflammation.31 Acute
toxicity from SM may be due to depletion of nicotinamide
adenine dinucleotide, eventually leading to coagulation
necrosis of cells and disruption of the dermal-epidermal
junction. All mucosal membranes of the respiratory tract,
including the sinonasal tract, are at risk for damage with
exposure.32 Symptomatology may not necessarily align
with objective evidence, such as in a case-control series
assessing computed tomography imaging of the sinuses of
returning combatants, which found no difference between
exposed and nonexposed individuals.33 In contrast, vet-
erans of the Iran-Iraq War (1980-1988) with a history of
SM exposure have been shown in a retrospective observa-
tional study to have increased chronic sinusitis as well as
laryngeal inflammation, postnasal drip, and dysphonia.34
In that study, analysis of biochemical markers, flexible
fiber-optic laryngoscopy, and computed tomography of
the sinuses revealed a high incidence of chronic sinusitis as
well as partial vocal fold immobility and inflammation.
Other classes of chemical weaponry have been the
subject of limited study with regard to URT health.
Organophosphates (OPs) are compounds that inhibit
acetylcholinesterase, resulting in augmented parasympa-
thetic nervous system activity and symptoms, including
rhinorrhea, lacrimation, and gastrointestinal motility.
These agents have been used as weapons throughout
modern history beginning in the 1930s and in World
War II (1939-1945).35 Military exposure in reference to
URT pathology is not well documented in the literature
and has predominantly focused on neurologic symptoms
and effects.36 One case report from Nigeria described
irreversible anosmia in a military officer exposed to OP pes-
ticide in close quarters.37 The long-term effects on the URT
with regard to combat exposure is not known; however,
there is some evidence suggesting that long-term occupa-
tional exposure does increase the risk for development of
asthma and other respiratory-related symptoms.38
Dioxin herbicides, notably Agent Orange, which gained
notoriety for use in the Vietnam War (1961-1971), may
also be associated with URT disease; however, there is very
limited evidence in the literature to support or refute this
observation. One report on the long-term effects of dioxin
exposure assessed a cohort of men exposed to 2,3,7,8-
tetrachlorodibenzo-p-dioxin and compared them to those
without exposure.39 The authors found a statistically sig-
nificant increase in the incidence of upper respiratory in-
fections compared with an unexposed cohort. A paucity of
evidence persists despite claims in popular media outlets
and anecdotal patient reports.
Etiologic considerations
Although a direct mechanism has not yet been established,
there is evidence to suggest a variety of factors that in-
crease the risk of URT and LRT pathology. There are more
data supporting etiology in LRT disease processes such as
asthma; however, extension of these mechanisms to the
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URT is likely when considering the concept of a unified
airway.
Numerous possible causes have been cited such as
particulate matter, close living quarters, exposure to oil
and burn pit smoke, microbes, and the presence of ambient
particulate matter. Most studies have failed to show a
correlation between open pit burning and fires and the
development of respiratory pathology.7,40–42 This finding
may be due in part to short durations of exposure. In
contrast, there is compelling evidence to suggest that close
living quarters is linked to spread of respiratory infectious
disease, which inevitably could lead to URT and LRT
symptoms.43–45 Despite this, there are no studies assessing
the long-term respiratory complications of close-quarters
living in combat zone populations, as much of the liter-
ature in that area is focused on pre-deployment military
recruits.
Environmental factors, notably the presence of inhaled
ambient particulate matter (PM), are believed to contribute
significantly to the development of many respiratory tract
disorders. Reports suggest PM as well as heavy metals may
be the cause of respiratory symptoms,46 and the size and
composition of the particulate play an important role in de-
termining which site of the respiratory system is affected.
Types of PM can range from sand and dust to exhaust,
fumes, and chemicals; the composition of which determines
the effect and the symptoms experienced by a patient.47
Furthermore, the size of the PM dictates the deposition
within the respiratory tract, as smaller particles have the
ability to travel more distally due to size. Fine PM is de-
fined as any particle <2.5 µm, and the maximum daily
exposure as suggested by the World Health Organization
is 25 µg/m3. In the Middle East the levels of fine PM can
exceed the recommended level and have been shown to be
as high as 111 µg/m3, suggesting an increased exposure risk
for troops in the region.48
The diversity of PM portends a wide array of aeroanti-
gens that can lead to sensitization and subsequent devel-
opment of allergic-type symptoms affecting the sinonasal
tract as well as the lower respiratory mucosa.27 Szema et al
developed an in vivo model to determine the pathogenesis
of the respiratory disease by exposing mice to dust collected
from Iraq. The dust from Iraq was found to induce higher
levels of lower airway inflammation when compared with
control dust from San Joaquin, California and Montana.
Furthermore, the dust samples from Iraq displayed particle
sizes as small as 2.5 µm and exhibited sharp edges, similar
to asbestos fibers, which have been found to lead to robust
lymphocytic airway inflammation in murine models.49 This
airway hyperresponsiveness to PM has been established
in other environments as well. A murine model assess-
ing inflammatory response to urban particulate matter in
Baltimore, Maryland, showed marked activation of the
complement cascade, specifically complement factor 3,
within the airway.50
In addition to ambient PM, soldiers are at increased risk
for exposure to other aerosolized chemicals and matter.
Discharge of munitions leads to release of a wide array
of chemicals and hard metals, which may also have an ef-
fect on the respiratory tract. Specifically, the discharge of
firearms leads to release of aerosolized lead particles that
can be inhaled, although the exact role of this material
on respiratory mucosa has not been evaluated.51 Despite
the plausible correlation with munitions exposures, this re-
mains as an area requiring further investigation.
Conclusion
Battlefield exposure has garnered increasing attention in
the past decade due to a large and important cohort of
soldiers in combat zones around the world. These service-
men and servicewomen return home from duty with com-
plaints involving the upper and lower respiratory tract, and
may have important albeit uncommon clinical histories that
make their diagnosis complicated and their treatment plans
unique. The majority of the literature examining this rela-
tionship is retrospective in nature and often limited by self-
reported symptomswithout objective diagnoses.Moreover,
the effect of combat exposure on URT disease has been the
subject of comparatively little study, with the result being
that the clinician must base evaluation and management
recommendations on the same principles used in the care
of individuals in the general population. Prospective and
large retrospective cohort studies are needed to establish
the association between soldiers returning from the battle-
field and the development of URT disease. This, in turn,
may have utility for physicians who treat combat veter-
ans with respiratory ailments. Until additional study has
been completed, it is important that practicing otolaryn-
gologists and other specialists remain aware of the possi-
bility of combat zone exposures that could contribute to
rhinologic symptomatology.
References
1. Kang HK, Mahan CM, Lee KY, Magee CA, Murphy
FM. Illnesses among United States veterans of the Gulf
War: a population-based survey of 30,000 veterans. J
Occup Environ Med. 2000;42:491–501.
2. Schwartz DA, Doebbeling BN, Merchant JA, Barret
DH. Self-reported illness and health status among
Gulf War veterans: a population-based study. JAMA.
1997;277:238–245.
3. Stecker T, Fortney J, Owen R, McGovern MP,
Williams S. Co-occurring medical, psychiatric, and
alcohol-related disorders among veterans returning
from Iraq and Afghanistan. Psychosomatics.
2010;51:503–507.
4. Sanders JW, Putnam SD, Frankart C, et al. Impact of
illness and non-combat injury during Operations Iraqi
Freedom and Enduring Freedom (Afghanistan). Am J
Trop Med Hyg. 2005;73:713–719.
5. Abraham JH, DeBakey SF, Reid L, Zhou J, Baird CP.
Does deployment to Iraq and Afghanistan affect res-
piratory health of US military personnel? J Occup En-
viron Med. 2012;54:740–745.
6. Morris MJ, Dodson DW, Lucero PF, et al. Study of
active duty military for pulmonary disease related to
environmental deployment exposures (STAMPEDE).
Am J Respir Crit Care Med. 2014;190:77–84.
7. Abraham JH, Eick-Cost A, Clark LL, et al. A retro-
spective cohort study of military deployment and post-
deployment medical encounters for respiratory condi-
tions. Mil Med. 2014;179:540–546.
8. Sharkey JM, Abraham JH, Clark LL, et al. Postde-
ployment respiratory health care encounters following
deployment to Kabul, Afghanistan: a retrospective co-
hort study. Mil Med. 2016;181:265–271.
9. Matthews T, Abraham J, Zacher LL, Morris MJ. The
impact of deployment on COPD in active duty mili-
tary personnel. Mil Med. 2014;179:1273–1278.
10. Szema AM, Salihi W, Savary K, Chen JJ. Respira-
tory symptoms necessitating spirometry among sol-
5 International Forum of Allergy & Rhinology, Vol. 00, No. 0, xxxx 2018
Parsel et al.
diers with Iraq/Afghanistan war lung injury. J Occup
Environ Med. 2011;53:961–965.
11. Barth SK, Dursa EK, Bossarte R, Schneiderman A.
Lifetime prevalence of respiratory diseases and expo-
sures among veterans of Operation Enduring Freedom
and Operation Iraqi Freedom Veterans: results from
the National Health Study for a New Generation of
US Veterans. J Occup Environ Med. 2016;58:1175–
1180.
12. Chen Y, Klein J, Ndirangu D, Smith W, Falvo M.
Deployment length and its correlation with spiromet-
ric variables in deployed veterans (882.1). FASEB J.
2014;28(Suppl):882–881.
13. Holley AB, Sobieszczyk M, Perkins M, et al. Lung
function abnormalities among service members re-
turning from Iraq or Afghanistan with respiratory
complaints. Respir Med. 2016;118:84–87.
14. Falvo MJ, Abraham JH, Osinubi OY, et al.
Bronchodilator responsiveness and airflow limita-
tion are associated with deployment length in Iraq
and Afghanistan veterans. J Occup Environ Med.
2016;58:325–328.
15. King MS, Eisenberg R, Newman JH, et al. Constric-
tive bronchiolitis in soldiers returning from Iraq and
Afghanistan. N Engl J Med. 2011;365:222–230.
16. DelVecchio SP, Collen JF, Zacher LL, Morris MJ. The
impact of combat deployment on asthma diagnosis
and severity. J Asthma. 2015;52:363–369.
17. Smith B, Wong CA, Smith TC, Boyko EJ, Gackstetter
GD. Newly reported respiratory symptoms and condi-
tions among military personnel deployed to Iraq and
Afghanistan: a prospective population-based study.
Am J Epidemiol. 2009;170:1433–1442.
18. Krouse JH. The unified airway—conceptual frame-
work. Otolaryngol Clin North Am. 2008;41:257–
266.
19. Passalacqua G, Ciprandi G, Canonica GW. United
airways disease: therapeutic aspects. Thorax.
2000;55(Suppl 2):S26–S27.
20. Braunstahl G-J, Kleinjan A, Overbeek SE, Prins J-B,
Hoogsteden HC, Fokkens WJ. Segmental bronchial
provocation induces nasal inflammation in aller-
gic rhinitis patients. Am J Respir Crit Care Med.
2000;161:2051–2057.
21. Brennan J. Experience of first deployed otolaryngol-
ogy team in Operation Iraqi Freedom: the changing
face of combat injuries.Otolaryngol Head Neck Surg.
2006;134:100–105.
22. Ladich ER. A histopathological study of head and
neck specimens from a cohort of Persian Gulf War
military veterans. Mil Med. 2002;167:864.
23. Richards AL, Hyams KC, Watts DM, Rozmajzl PJ,
Woody JN, Merrell BR. Respiratory disease among
military personnel in Saudi Arabia during Operation
Desert Shield. Am J Public Health. 1993;83:1326–
1329.
24. Kelsall H, Sim M, Forbes A, et al. Symptoms and
medical conditions in Australian veterans of the 1991
Gulf War: relation to immunisations and other Gulf
War exposures. Occup Environ Med. 2004;61:1006–
1013.
25. Barth SK, Dursa EK, Peterson MR, Schneiderman
A. Prevalence of respiratory diseases among veter-
ans of Operation Enduring Freedom and Operation
Iraqi Freedom: results from the National Health Study
for a New Generation of US Veterans. Mil Med.
2014;179:241–245.
26. Szema A, Peters M,Weissinger K, Gagliano C, Chen J.
Increased allergic rhinitis rates among US military per-
sonnel after deployment to the Persian Gulf. J Allergy
Clin Immunol. 2008;121(Suppl):S230.
27. Waibel KH. Allergic rhinitis in the Middle East. Mil
Med. 2005;170:1026.
28. Katelaris CH, Lee BW, Potter PC, et al. Prevalence and
diversity of allergic rhinitis in regions of the world be-
yond Europe and North America. Clin Exp Allergy.
2012;42:186–207.
29. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhini-
tis and its impact on asthma (ARIA) 2008. Allergy.
2008;63(Suppl 86):8–160.
30. Siracusa A, Desrosiers M, Marabini A. Epidemiology
of occupational rhinitis: prevalence, aetiology and de-
terminants. Clin Exp Allergy. 2000;30:1519–1534.
31. Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell
FR. Sulfur mustard: its continuing threat as a chemical
warfare agent, the cutaneous lesions induced, progress
in understanding its mechanism of action, its long-
term health effects, and new developments for protec-
tion and therapy. J AmAcad Dermatol. 1995;32:765–
776.
32. Balali-Mood M, Hefazi M. The pharmacology, toxi-
cology, andmedical treatment of sulphurmustard poi-
soning. Fundam Clin Pharmacol. 2005;19:297–315.
33. Ghanei M, Harandi AA, Rezaei F, Vasei A. Sinus CT
scan findings in patients with chronic cough following
sulfur mustard inhalation: a case-control study. Inhal
Toxicol 2006;18:1135–1138.
34. Balali-Mood M, Afshari R, Zojaji R, et al. Delayed
toxic effects of sulfur mustard on respiratory tract of
Iranian veterans. Hum Exp Toxicol. 2011;30:1141–
1149.
35. Delfino RT, Ribeiro TS, Figueroa-Villar JD.
Organophosphorus compounds as chemical warfare
agents: a review. J Brazil Chem Soc. 2009;20:407–
428.
36. Brown MA, Brix KA. Review of health consequences
from high-, intermediate- and low-level exposure
to organophosphorus nerve agents. J Appl Toxicol.
1998;18:393–408.
37. Ngamdu Y, Sandabe M, Kodiya A, Isa A, Garandawa
H. Sudden anosmia due to otapiapia (organophos-
phate pesticide) exposure. J Case Rep. 2012;2:31–32.
38. Eskenazi B, Bradman A, Castorina R. Exposures of
children to organophosphate pesticides and their po-
tential adverse health effects.EnvironHealth Perspect.
1999;107(Suppl 3):409.
39. Zober A, Ott MG, Messerer P. Morbidity follow
up study of BASF employees exposed to 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) after a 1953
chemical reactor incident. Occup Environ Med.
1994;51:479–486.
40. Rohrbeck P, Hu Z, Mallon TM. Assessing health out-
comes after environmental exposures associated with
open pit burning in deployed US service members. J
Occup Environ Med. 2016;58(Suppl 1):S104–110.
41. Hines SE, Gucer P, Kligerman S, et al. Pulmonary
health effects in Gulf War I service members ex-
posed to depleted uranium. J Occup Environ Med.
2013;55:937–944.
42. Baird CP, DeBakey S, Reid L, Hauschild VD, Petruc-
celli B, Abraham JH. Respiratory health status of US
Army personnel potentially exposed to smoke from
2003 Al-Mishraq sulfur plant fire. J Occup Environ
Med. 2012;54:717–723.
43. Kak V. Infections in confined spaces: cruise ships, mili-
tary barracks, and college dormitories. Infect Dis Clin
North Am. 2007;21:773–784.
44. Paparello SF, Garst P, Bourgeois AL, Hyams KC. Di-
arrheal and respiratory disease aboard the hospital
ship, USNSMercy T-AH 19, during Operation Desert
Shield. Mil Med. 1993;158:392–395.
45. Murray CK, Horvath LL, Ericsson CD, Hatz C. An
approach to prevention of infectious diseases during
military deployments. Clin Infect Dis. 2007;44:424–
430.
46. Dodson D, Kwon HP, Zacher L. Gold and teflon
from transbronchial biopsies of a combat veteran with
shortness of breath after exposure to burn pits in Iraq.
Chest. 2010;138:80A.
47. Weese CB, Abraham JH. Potential health implica-
tions associated with particulate matter exposure in
deployed settings in southwest Asia. Inhal Toxicol.
2009;21:291–296.
48. Engelbrecht JP, McDonald EV, Gillies JA, Jayanty R,
Casuccio G, Gertler AW. Characterizing mineral dusts
and other aerosols from the Middle East—part 1: am-
bient sampling. Inhal Toxicol. 2009;21:297–326.
49. Szema AM, Reeder RJ, Harrington AD, et al. Iraq dust
is respirable, sharp, metal-laden, and induces lung in-
flammation with fibrosis in mice via IL-2 upregulation
and depletion of regulatory T cells. J Occup Environ
Med. 2014;56:243.
50. Walters DM, Breysse PN, Schofield B, Wills-Karp M.
Complement factor 3 mediates particulate matter–
induced airway hyperresponsiveness.Am J Respir Cell
Mol Biol. 2002;27:413–418.
51. Czarnecki F. Chemical hazards in law enforcement.
Clin Occup Environ Med. 2003;3:443–456.
International Forum of Allergy & Rhinology, Vol. 00, No. 0, xxxx 2018 6
